Respiratory/Pulmonary Market Research Reports & Industry Analysis

Kentley Insights’ 2025 Diseases of the Respiratory System Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with ...

Cystic Fibrosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Cystic Fibrosis - Global Clinical Trials Review, 2025 provides an overview of Cystic Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cystic Fibr ...

Pulmonary Tuberculosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Pulmonary Tuberculosis - Global Clinical Trials Review, 2025 provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical ...

Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029 The chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7841 mn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the chronic obstructive pulmonary disease drugs market p ...

The global digital stethoscopes market is projected to reach USD 0.71 billion by 2032 from USD 0.49 billion in 2025, at a CAGR of 5.5% during the forecast period. The global digital stethoscopes market is driven by the growth of telemedicine, remote patient monitoring, and the increasing prevalence ...

The global intubation market is set to experience significant growth over the next decade, expanding from a projected US$ 1.5 billion in 2025 to US$ 2.42 billion by 2032. This growth, driven by a strong CAGR of 7.12%, reflects increasing demand for advanced airway management solutions in surgical pr ...

The pressure monitoring market is projected to reach USD 25.48 billion by 2032 from USD 14.56 billion in 2025, at a CAGR of 8.3% from 2025 to 2032. Technological innovations, such as the development of non-invasive, portable, and connected monitoring devices, have improved the accessibility and conv ...

This study covers the world outlook for pulmonary fibrosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ...

This study covers the world outlook for pulmonary drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for pulmonary arterial hypertension across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for respiratory care devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for respiratory disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the re ...

This study covers the world outlook for respiratory inhalers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for respiratory monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for plethysmograph across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region ...

This study covers the world outlook for pulmonary function testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ...

This study covers the world outlook for respiratory diagnostics for tuberculosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share th ...

This study covers the world outlook for non-small cell lung cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for pulmonary-respiratory drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the c ...

This study covers the world outlook for pulmonary drug delivery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ...

This study covers the world outlook for swine respiratory diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the c ...

This study covers the world outlook for pulmonary and respiratory drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share t ...

This study covers the world outlook for respiratory drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the reg ...

This study covers the world outlook for respiratory complications therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...